Prognostic impact of Skp2, ER and PGR in male and female patients with soft tissue sarcomas

Table 3 Expression of markers, gender and their prediction for disease-specific survival in patients with soft tissue sarcomas (univariate analysis; log-rank test), All = 193, Males = 81, Females = 112

Marker expression	Patients (n)	Patients (%)	Median survival (months)	5-year survival (%)	P
Skp2, all
Low	109	56	NR	63	0.050
High	67	45	59	50
Missing	17	9
Skp2, men
Low	50	62	NR	63	0.577
High	23	28	67	61
Missing	8	10
Skp2, women
Low	59	53	NR	63	0.066
High	44	39	49	44
Missing	9	8
ER, all
Low	112	58	123	57	0.725
High	72	67	91	57
Missing	9	5
ER, men
Low	49	60	NR	69	0.089
High	29	36	58	49
Missing	3	4
ER, women
Low	63	56	57	47	0.041
High	43	38	NR	62
Missing	6	5
PGR, all
Low	132	68	NR	62	0.101
High	57	30	52	46
Missing	4	2
PGR, men
Low	64	79	NR	69	0.010
High	15	19	41	33
Missing	2	2
PGR, women
Low	68	61	80	55	0.832
High	42	38	74	51
Missing	2	2